UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Impact of common risk factors of fibrosis progression in chronic hepatitis C

Gut, 2015-10, Vol.64 (10), p.1605-1615

2015

Volltextzugriff (PDF)

Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis

The pharmacogenomics journal, 2014-08, Vol.14 (4), p.350-355

2014

Volltextzugriff (PDF)

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

The pharmacogenomics journal, 2017-07, Vol.17 (4), p.312-318

2017

Volltextzugriff (PDF)

Impact of student-initiated green chemistry experiments on their knowledge, awareness and practices of environmental sustainability

Journal of physics. Conference series, 2019-01, Vol.1156 (1), p.12022

2019

Volltextzugriff (PDF)

SCN1A variations and response to multiple antiepileptic drugs

The pharmacogenomics journal, 2014-08, Vol.14 (4), p.385-389

2014

Volltextzugriff (PDF)

Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent

Genes and immunity, 2014-03, Vol.15 (2), p.88-94

2014

Volltextzugriff (PDF)

The CTLA4 +49 A/GG-CT60G haplotype is associated with susceptibility to multiple sclerosis in Flanders

Journal of neuroimmunology, 2005-07, Vol.164 (1-2), p.148-153

2005

Volltextzugriff (PDF)

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity

Journal of clinical pharmacy and therapeutics, 2014-10, Vol.39 (5), p.555-560

2014

Volltextzugriff (PDF)

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

Genes and immunity, 2013-07, Vol.14 (5), p.286-290

2013

Volltextzugriff (PDF)

Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl

Pain medicine (Malden, Mass.), 2017-12, Vol.18 (12), p.2369-2387

2017

Volltextzugriff (PDF)

1328 IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S524-S524

2011

Volltextzugriff (PDF)

1152 IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S455-S455

2011

Volltextzugriff (PDF)

813 HEPATITIS C VIRUS-SPECIFIC CELLULAR IMMUNITY DOES NOT PROTECT AGAINST FUTURE HCV INFECTION IN ANTI-HCV NEGATIVE INJECTING DRUG USERS

Journal of hepatology, 2011-03, Vol.54, p.S326-S326

2011

Volltextzugriff (PDF)

The CTLA4 + 49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland

Experimental and molecular pathology, 2006-04, Vol.80 (2), p.141-146

2006

Volltextzugriff (PDF)

1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S551-S551

2012

Volltextzugriff (PDF)

Polymorphisms in the interleukin-4 and IL-4 receptor genes modify risk for chronic inflammatory arthropathies in women

Experimental and molecular pathology, 2006-12, Vol.81 (3), p.239-244

2006

Volltextzugriff (PDF)

Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations

International journal of immunogenetics, 2005-12, Vol.32 (6), p.383-388

2005

Volltextzugriff (PDF)

CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland

Journal of neuroimmunology, 2007-07, Vol.187 (1), p.187-191

2007

Volltextzugriff (PDF)

Genetics of autoimmune diseases. A study of immuno-regulatory genes: CTLA-4, IL-4, IL4RA, SOCS3, IFNG and IL26 in multiple sclerosis, rheumatoid arthritis and juvenile idiopathic arthritis

Suppiah, V

2007

Volltextzugriff (PDF)

The CTLA4 + 49 A/G G– CT60 G haplotype is associated with susceptibility to multiple sclerosis in Flanders

Journal of neuroimmunology, 2005, Vol.164 (1), p.148-153

2005

Volltextzugriff (PDF)

Accentuate the positive

The Health service journal, 1989-01, Vol.99 (5135), p.109

Suppiah, V

1989

Volltextzugriff (PDF)

Promises to keep

Health Service Journal, 1993-02, Vol.103 (5339), p.20-21

1993

Volltextzugriff (PDF)

Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States

PloS one, 2022-11, Vol.17 (11), p.e0277713

2022

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of common risk factors of fibrosis progression in chronic hepatitis C

Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

Impact of student-initiated green chemistry experiments on their knowledge, awareness and practices of environmental sustainability

SCN1A variations and response to multiple antiepileptic drugs

Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent

The CTLA4 +49 A/GG-CT60G haplotype is associated with susceptibility to multiple sclerosis in Flanders

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl

1328 IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION

1152 IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION

813 HEPATITIS C VIRUS-SPECIFIC CELLULAR IMMUNITY DOES NOT PROTECT AGAINST FUTURE HCV INFECTION IN ANTI-HCV NEGATIVE INJECTING DRUG USERS

The CTLA4 + 49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland

1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS

Polymorphisms in the interleukin-4 and IL-4 receptor genes modify risk for chronic inflammatory arthropathies in women

Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations

CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland

CCR5-[Delta]32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

CCR5- Delta 32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

Genetics of autoimmune diseases. A study of immuno-regulatory genes: CTLA-4, IL-4, IL4RA, SOCS3, IFNG and IL26 in multiple sclerosis, rheumatoid arthritis and juvenile idiopathic arthritis

The CTLA4 + 49 A/G G– CT60 G haplotype is associated with susceptibility to multiple sclerosis in Flanders

Accentuate the positive

Promises to keep

Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States

Suchergebnisse filtern